Evidence map›Paper›PMID 41630403›Full record

ArticleCurrent organic synthesis2025

Quantitative Structure-Property Relationship (QSPR) Modeling of Central Nervous System (CNS) Drug Activity using Molecular Descriptors.

Jeyaraj Sahaya Vijay, Roy Santiago, Mohamad Azeem, Tony Augustine, Mohamad Nazri Husin

Abstract read
PubMed Publisher
In one paragraph

Article in Current organic synthesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeyaraj Sahaya VijayVellore Institute of Technology, School of Advanced Sciences, Vellore, India.
Roy SantiagoVellore Institute of Technology, School of Advanced Sciences, Vellore, India.
Mohamad AzeemDepartment of Mathematics, Riphah International University, Lahore, 54000, Pakistan.
Tony AugustineDepartment of Mathematics, Nirmala College (Autonomous), Muvattupuzha, Ernakulam, Kerala, 686661, India.
Mohamad Nazri HusinUniversity Malaysia Terengganu, Department of Computer Science and Mathematics, Terengganu, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundL-type amino acid transporter-1 is a drug that stimulates the functions of the brain's central nervous system. Membrane transporters have evolved, leading to a distinct approach in L-type amino acid transporter-1 drug delivery. One of the transporters used for transporting drugs across biological membranes is the L-type amino acid transporter-1. It is widely discussed in the medicinal field.

objectivesNumerous investigations indicate a close connection between the properties of alkanes and the diversity of central nervous system drugs in the brain, specifically log P and molecular weight. One important study that analyzes structural properties is focused on topological descriptors. Recently, topological indices have found application in the development of quantitative structure-activity relationships. These indices are correlated with the physicochemical properties of BCNS-acting drugs and their biological activity.

methodsThe study employs significant methods of calculating topological indices: the edge set partition method and the Djokovi´c-Winkler relation (cut method) are utilized to calculate the values of these descriptors.

resultsThe results of distance and degree-based topological descriptors have been derived. The strong correlation between topological descriptors and the physicochemical properties of BCNS-acting drugs has been studied.

conclusionsThis article identifies important topological features for various CNS medications, aiming to support researchers in understanding the properties of molecules and their biological activity. Furthermore, we demonstrate how strongly these behaviors correspond to the physicochemical properties of central nervous system drugs.

Indexed as

Central Nervous SystemCentral Nervous System AgentsQuantitative Structure-Activity RelationshipHumansCentral Nervous System Agentscentral nervous system acting drugsdjokovi´c-winkler.linear regression modelsL-type amino acid transporter-1QSPR analysistopological descriptors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.